Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 3 studies | 18% ± 2% |
Insufficient scRNA-seq data for expression of CHST14 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 100% | 1430.53 | 1809 / 1809 | 100% | 68.52 | 472 / 472 |
prostate | 100% | 1534.03 | 245 / 245 | 100% | 54.82 | 501 / 502 |
ovary | 100% | 2091.05 | 180 / 180 | 100% | 45.30 | 429 / 430 |
thymus | 100% | 1745.68 | 653 / 653 | 99% | 44.57 | 601 / 605 |
kidney | 100% | 898.53 | 89 / 89 | 99% | 52.46 | 894 / 901 |
breast | 100% | 1510.18 | 459 / 459 | 99% | 46.48 | 1109 / 1118 |
lung | 100% | 1395.79 | 578 / 578 | 99% | 46.33 | 1142 / 1155 |
uterus | 100% | 2193.46 | 170 / 170 | 98% | 48.09 | 452 / 459 |
bladder | 100% | 1664.62 | 21 / 21 | 98% | 38.65 | 495 / 504 |
adrenal gland | 100% | 969.25 | 257 / 258 | 97% | 38.41 | 222 / 230 |
esophagus | 100% | 1117.63 | 1441 / 1445 | 96% | 37.05 | 176 / 183 |
intestine | 100% | 1067.96 | 964 / 966 | 95% | 24.55 | 503 / 527 |
stomach | 100% | 809.74 | 359 / 359 | 95% | 24.85 | 272 / 286 |
pancreas | 96% | 489.03 | 316 / 328 | 98% | 44.44 | 174 / 178 |
liver | 99% | 479.26 | 224 / 226 | 92% | 21.17 | 374 / 406 |
brain | 79% | 286.44 | 2085 / 2642 | 99% | 45.16 | 699 / 705 |
adipose | 100% | 1461.81 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1653.31 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 54.88 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 25.10 | 29 / 29 |
spleen | 100% | 1371.10 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 48.10 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 32.13 | 1 / 1 |
heart | 100% | 867.18 | 857 / 861 | 0% | 0 | 0 / 0 |
muscle | 67% | 222.72 | 537 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 65% | 384.80 | 603 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030208 | Biological process | dermatan sulfate biosynthetic process |
GO_0050655 | Biological process | dermatan sulfate proteoglycan metabolic process |
GO_0016051 | Biological process | carbohydrate biosynthetic process |
GO_0000139 | Cellular component | Golgi membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0016020 | Cellular component | membrane |
GO_0001537 | Molecular function | N-acetylgalactosamine 4-O-sulfotransferase activity |
GO_0042301 | Molecular function | phosphate ion binding |
GO_0008146 | Molecular function | sulfotransferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | CHST14 |
Protein name | Carbohydrate sulfotransferase 14 (EC 2.8.2.35) (Dermatan 4-sulfotransferase 1) (D4ST-1) (hD4ST1) Carbohydrate sulfotransferase (EC 2.8.2.-) |
Synonyms | UNQ1925/PRO4400 D4ST1 |
Description | FUNCTION: Catalyzes the transfer of sulfate to position 4 of the N-acetylgalactosamine (GalNAc) residue of dermatan sulfate. Plays a pivotal role in the formation of 4-0-sulfated IdoA blocks in dermatan sulfate. Transfers sulfate to the C-4 hydroxyl of beta1,4-linked GalNAc that is substituted with an alpha-linked iduronic acid (IdoUA) at the C-3 hydroxyl. Transfers sulfate more efficiently to GalNAc residues in -IdoUA-GalNAc-IdoUA- than in -GlcUA-GalNAc-GlcUA-sequences. Has preference for partially desulfated dermatan sulfate. Addition of sulfate to GalNAc may occur immediately after epimerization of GlcUA to IdoUA. Appears to have an important role in the formation of the cerebellar neural network during postnatal brain development. . |
Accessions | Q8NCH0 H0YN65 ENST00000306243.7 ENST00000559991.1 |